The Promise and Challenge of GLP-1 Medications: Ensuring ROI in Obesity Care
Pricy GLP-1 medications are here to stay — let's focus on turning their potential into lasting, meaningful impact.
Why Medicare Should Treat Obesity as a Disease
Medicare is failing its beneficiaries by not treating obesity as a disease. Just like people with high blood pressure often need to take medications to avoid disease-related complications, people with obesity need access to all appropriate, evidence-based therapies to combat the disease.
Balancing the Role of Physicians and AI [Video]
At the ViVE conference in LA, Smarter Technologies Chief Medical Officer Ruben Amarasingham MD talked with Katie Adams about the company's larger goals for AI: to improve the accuracy of data and make healthcare less burdensome for physicians and clinicians.